
USFDA26 Aug 2025, 08:21 pm
Dishman Carbogen Amcis Ltd Receives EIR from US FDA for Naroda Unit
AI Summary
Dishman Carbogen Amcis Ltd has announced that its Naroda unit has received an Establishment Inspection Report (EIR) from the US FDA. The Naroda facility was inspected by the US FDA between 9th June, 2025 and 13th June, 2025, and the inspection was successfully completed on 12th June, 2025. The company had previously intimated the stock exchange about the successful completion of the inspection on 13th June, 2025. The receipt of the EIR indicates the closure of the inspection. The company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the US FDA.
Key Highlights
- Dishman Carbogen Amcis Ltd's Naroda unit receives EIR from US FDA
- Naroda facility was inspected by the US FDA between 9th June, 2025 and 13th June, 2025
- The inspection was successfully completed on 12th June, 2025
- Company had previously intimated the stock exchange about the successful completion of the inspection on 13th June, 2025
- Receipt of the EIR indicates the closure of the inspection